Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tilray Brands Inc (NQ: TLRY )

1.700 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Tilray Brands Inc

< Previous 1 2 3 4 5 6 7 8 9
...
87 88 Next >
Here's Where To Buy Legal Weed While Getting A Tattoo And A Beer: New Cannabis Stores In US And More
These days, smaller players in the alcohol industry are opting to venture into cannabis. As highlighted in a recent story by Green Market Report's John Schroyer, Beer World located in Greene County,... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Where Will Tilray Brands Be in 3 Years?
Can this beaten-down pot stock turn things around? 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
1 New Reason to Consider Buying Tilray Brands Stock, and 1 New Reason to Sell
There's now a silver lining to the latest setback. 
Via The Motley Fool
Largest Cannabis Stocks Declined 31%, On Average, In May
The 12 largest cannabis stocks spent May giving back most of their late-April gains; they are still up 24% YTD. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
3 Meme Stocks That Could Be Millionaire-Makers: May Edition
These are the meme stocks to buy that represent companies pursuing aggressive expansion plans that will imply robust growth. 
Via InvestorPlace
Is Tilray Brands Preparing for a Big U.S.-Based Acquisition?
Acquisitions have played a big role in Tilray Brands' strategy, and the company is still not done wheeling and dealing. 
Via The Motley Fool
The Penny Stock Jackpot: 3 Hidden Gems to Uncover Before Wall Street Does
These are three penny stocks to buy before Wall Street catches the scent and investors send shares higher. 
Via InvestorPlace
Schedule III Windfall: 3 Stocks to Buy BEORE the Cannabis Reclassification
These are the cannabis stocks to buy that represent companies with good fundamentals and aggressive expansion plans. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
All 12 Constituents In The Cannabis Portfolios Declined W/e May 24th
All 12 constituents declined w/e by an average of 14.4% and are now down 28.9%, on average, since Tuesday, April 30th, when the DEA announced it planned to reclassify cannabis as a less regulated... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Tilray Brands Slashed Its Guidance. Is the Stock a Buy?
This worse-than-expected news is not necessarily a sign to buy the dip. 
Via The Motley Fool
3 Cannabis Stocks to Buy Now: May 2024
These cannabis stocks to buy offer the best odds at capturing long-term upside from current rescheduling initiatives. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Weed Out the Weak: 3 Choking Cannabis Stocks to Cut Now
Investors should sell these cannabis stocks despite recent positive news since nothing has really changed. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
What's Going On With Tilray Brands Stock?
Tilray has announced the Warming Deep Tissue Stick as the latest addition to its Solei cannabis wellness brand. The brand's first cannabis-infused roll-on topical is focused on capturing the interest... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Contrarian Bets: 3 Stocks Wall Street Hates That You Should Love
Even though Wall Street doesn't like these companies they are contrarian stocks to buy with significant tailwinds to push them forward. 
Via InvestorPlace
Easy-To-Trade Cannabis Stocks: Insights Into How Trading Activity Affects These Investments
The trading volume of a stock reflects the number of shares bought and sold within a given time. This is called liquidity. The term is used because it likens the ease of converting assets to cash to... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Rallied After Rescheduling News, Investment Management Firm Co-Founder Discusses Impact And Next Steps
Explore how DOJ's cannabis rescheduling boosts stocks and insights from Emily Paxhia on the industry's future. Read now! 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Rescheduling: When Will It Happen? Expert Lays Out Timeline, Risks And Wild Cards
The Department of Justice (DOJ) confirmed that it has started the formal rulemaking process to reclassify cannabis to Schedule III. This significant step reinforces the positive outlook for cannabis... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Is Tilray Brands Stock a Buy?
Despite a broad rally in cannabis, this top Canadian LP has failed to join the party. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Canadian Cannabis LPs Portfolio Up 14% This Week; Still Down 21% MTD
The Portfolio was up 14.1% this week but is still finding its level, off almost 21% from its spike from the April 30th DEA announcement. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Benzinga Bulls And Bears: Tesla, GameStop, Tilray And Crypto Trader Says Shiba Inu Could 4X
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories. The Dow Jones Industrial Average made history on Friday by closing... 
Via Benzinga
Topics Stocks
Exposures US Equities
Cannabis Stock Movers For May 17, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
The 3 Most Undervalued Penny Stocks to Buy in May 2024
Penny stock investing is a fool's errand but never say never as there are still a few undervalued penny stocks to buy. 
Via InvestorPlace
Dear CGC Stock Fans, Mark Your Calendars for May 30
CGC stock continues to climb today following the DOJ's proposal to reschedule cannabis to a Schedule III drug, from a Schedule I. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
What's Going On With Cannabis-Producer Akanda's Stock?
The Department of Justice reportedly planned to issue a notice of proposed rulemaking on Thursday that would reclassify marijuana to Schedule III after a 60-day public comment period. Major players in... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Launches $250M At-The-Market Program To Boost Acquisitions, Eyes Expansion With U.S. Cannabis Rescheduling
Tilray launches a $250M ATM program to fund strategic acquisitions and leverage U.S. cannabis rescheduling when effective. Read now! 
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Must-Buy Meme Stocks When Prices Plunge
These are the meme stocks to buy on corrections as they represent companies with impending growth catalysts. 
Via InvestorPlace
Cannabis Stocks CGC, TLRY, ACB, MSOS, CRON Pop as Justice Department Moves on Rescheduling
Cannabis stocks are among the big movers investors are watching closely as a key piece of legislation is pushed forward for this sector. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Weed Industry Celebrates Biden's Rescheduling Move: 'Most Monumental Cannabis Reform In Half A Century'
Cannabis companies and advocates applaud President Biden's announcement to reschedule and legalize cannabis, calling it a major leap forward and opportunity to correct long-standing wrongs and improve... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Weed Stocks Rally After Biden Makes Marijuana Reclassification Announcement
Shares of marijuana growers and related companies are trading higher Thursday after President Biden announced that the Department of Justice has moved to reclassify marijuana from a Schedule I... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Biden Announces 'Monumental' Marijuana Rescheduling, DOJ To Take Next Steps
Biden announces plan to reclassify marijuana from Schedule I to III, reversing inequities and removing barriers for Americans. Cannabis stocks rise. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
87 88 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.